Literature DB >> 9543372

Subclinical activation of lupus nephritis by recombinant human growth hormone.

H K Yap1, K Y Loke, B Murugasu, B W Lee.   

Abstract

The effect of growth hormone (GH) on subclinical disease activity in a 15-year-old boy with previously quiescent lupus nephritis and chronic renal failure is described. Institution of supraphysiological doses of GH resulted in a rise in erythrocyte sedimentation rate, decrease in serum complement, rise in anti-DNA antibody titers, and increase in T-cell activation markers, all of which improved following cessation of GH treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543372     DOI: 10.1007/s004670050421

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  3 in total

Review 1.  Pediatric SLE--towards a comprehensive management plan.

Authors:  Hermine I Brunner; Jennifer Huggins; Marisa S Klein-Gitelman
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543

2.  Age-related changes in serum growth hormone, insulin-like growth factor-1 and somatostatin in system lupus erythematosus.

Authors:  Charles W Denko; Charles J Malemud
Journal:  BMC Musculoskelet Disord       Date:  2004-10-20       Impact factor: 2.362

3.  Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis.

Authors:  Merav Heshin-Bekenstein; Liat Perl; Aimee O Hersh; Emily von Scheven; Ed Yelin; Laura Trupin; Jinoos Yazdany; Erica F Lawson
Journal:  Pediatr Rheumatol Online J       Date:  2018-04-23       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.